Presurgical treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab may improve tumor control in patients with stage III cutaneous melanoma, according to a recent study published by Davar et al in Cancer Cell.
Melanoma News
Latest data reveals NSW’s top melanoma hotspots
The Cancer Institute NSW’s newly released melanoma hotspot map reveals Ballina, Lismore, Byron, Clarence Valley and Coffs Harbour local government areas (LGAs) have the state’s highest rates of melanoma, with almost 350 cases projected to be diagnosed in those areas in 2024.
Wide local excision, Mohs remain primary treatment options for positive tumor margins
Positive margins are infrequent following standard excision, but when they do occur it is mostly in the upper extremities.
Quick Chat About Skin Cancer with Yale Dermatologist Sean Christensen
Skin cancer is the most common type of cancer in the United States, with millions of cases diagnosed each year. According to the National Institutes of Health (NIH), basal cell carcinoma and squamous cell carcinoma are the most frequently occurring forms, with over 4 million and 1 million cases annually, respectively.